Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis

NCT04474938 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Amyloidosis; Systemic

Interventions

DRUG: Daratumumab
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Peking Union Medical College Hospital

Collaborators

[object Object]